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Abstract. Many integrins recognize short RGD-con- 
taining amino acid sequences and such peptide se- 
quences can be identified from phage libraries by pan- 
ning with an integrin. Here, in a reverse strategy, we 
have used such libraries to isolate minimal receptor se- 
quences that bind to fibronectin and RGD-containing 
fibronectin fragments in affinity panning. A predomi- 
nant cyclic motif, *CWDDC/LWLC  *, was obtained (the 
asterisks denote a potential disulfide bond). Studies us- 
ing the purified phage and the corresponding synthetic 
cyclic peptides showed that *CWDDGWLC*-express- 
ing phage binds specifically to fibronectin and to fibro- 
nectin fragments containing the RGD sequence. The 
binding did not require divalent cations and was inhib- 
ited by both RGD and *CWDDGWLC*-containing 
synthetic peptides. Conversely, RGD-expressing phage 
attached specifically to immobilized *CWDDGWLC*- 
peptide and the binding could be blocked by the re- 
spective synthetic peptides in solution. Moreover, fi- 
bronectin bound to a *CWDDGWLC*-peptide affinity 
column, and could be eluted with an RGD-containing 
peptide. The *CWDDGWLC*-peptide inhibited 
RGD-dependent cell attachment to fibronectin and vi- 
tronectin, but not to collagen. A region of the [3 subunit 
of RGD-binding integrins that has been previously 
demonstrated to be involved in ligand binding includes 
a polypeptide stretch, KDDLW (in [33) similar to 
WDDC/LWL. Synthetic peptides corresponding to this 
region in [33 were found to bind RGD-displaying phage 
and conversion of its two aspartic residues into alanines 
greatly reduced the RGD binding. Polyclonal antibod- 
ies raised against the *CWDDGWLC*-peptide recog- 
nized [31 and [~3 in immunoblots. These data indicate 
that the *CWDDGWLC*-peptide is a functional 
mimic of ligand binding sites of RGD-directed inte- 
grins, and that the structurally similar site in the inte- 
grin t3 subunit is a binding site for RGD. 
I 
NTEGRINS are heterodimeric glycoproteins formed by 
the association of an tx and a 13 subunit; they mediate 
cell-matrix and cell-cell interactions that are impor- 
tant in biological events such as cell differentiation, malig- 
nant transformation, immune recognition, and blood coag- 
ulation  (13,  16,  19,  38).  Some of the  integrin effects in 
these phenomena are the consequence of physical adhe- 
sion, others are mediated by signal transduction through 
integrin cytoplasmic domains (17, 20, 30, 46). 
An  important  integrin  binding  site  is  the  tripeptide 
RGD, present in a variety of integrin ligands. In fibronec- 
tin, it is located in the tenth type III repeat (III10)  1 (34, 35), 
the structure of which has been elucidated by NMR (26) 
and  crystallography (11).  Studies  with  fibronectin  frag- 
ments  and  phage  display  libraries  have  suggested  that 
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1. Abbreviation used in this paper: IIIa0, tenth type III repeat. 
other sites in this region of fibronectin are also needed for 
full integrin-binding activity (4, 23, 31). 
Contact regions for the RGD sequence have been iden- 
tified in the integrin subunits (14). Affinity cross-linking of 
RGD  peptides  and  site-directed  mutagenesis  localize  a 
ligand-binding site in the alIb[33  integrin at amino acid 
residues 109-172 of the [~ subunit (2, 3, 6, 8, 33).  Studies 
with  the  av133 integrin  place  an  RGD-binding  site  at 
amino acids 61-203 (41), and a similar cross-linking region, 
amino acids 120-140 in the [31 subunit, has also been found 
to be  involved in ligand binding (43).  In each case, the 
RGD-binding site is near or at a site that binds divalent 
cations. The c~ subunit also contains one or more ligand- 
binding sites; as with the 13 subunits, these sites localize to 
the divalent cation binding sequences (5, 7, 12, 25, 27). 
Our laboratory has used random peptide libraries dis- 
played on phage (40) to study the structural requirements 
in the RGD-type peptide ligands for their binding to inte- 
grins. Searches of such libraries have confirmed the central 
role of the RGD sequence in ligand binding by several in- 
tegrins and have also revealed auxiliary binding sites in the 
ligands (15, 21-24, 29, 42). Here we have used the reverse 
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grins that are important for ligand binding. We report here 
the identification and characterization of an RGD-binding 
sequence, *CWDDGWLC*, from a random phage display 
library. This peptide is similar to key residues in the inte- 
grin ligand binding site and thus appears to be a structural 
mimic of an RGD contact point in integrins. 
Materials and Methods 
Materials 
Human plasma fibronectin was from the Finnish Red Cross (Helsinki, 
Finland). A  110-kD fragment of fibronectin was prepared  as described 
previously (34).  Recombinant fibronectin fragments containing type III 
repeats 8 and 9, 9 and 10, 10 and 11, 10 alone, and 8 through 11 were pro- 
duced as described (10), using GST (Pharmacia, Uppsala, Sweden) (for 
the 8 through 11 fragment) and His-Tag (Qiagen, Chatsworth, CA) (for 
the other four fragments) fusion protein systems. A fragment encompass- 
ing the alternatively spliced cell attachment domain of fibronectin (amino 
acids 1860-2140)  was also produced using the His-Tag system. Vitronectin 
was purified from human plasma as described (47).  Collagen was from 
Collaborative Research (Bedford, MA), sheep red blood cells were from 
Sigma.  Purified  MIb133  was  from  Enzyme Research Laboratories  Inc. 
(South Bend, IN). Anti-131 monoclonal antibody TS2/16 was a gift from 
Dr.  Martin  Hemler  (Dana  Farber  Cancer  Institute,  Harvard  Medical 
School, Boston, MA). Peptides were synthesized on a synthesizer (Model 
430A; Applied Biosystems, Foster City, CA) by standard Merrifield solid 
phase synthesis protocols and t-butoxycarbonyl chemistry. Cyclic peptides 
were prepared by oxidizing with 0.01  M  K3Fe(CN)6 at pH 8.4 overnight 
and purified by reverse-phase HPLC. The peptide structures were con- 
firmed by mass spectroscopy. Phage display libraries were made as de- 
scribed (22-24) using the fuse 5 vector (40). 
Panning of Phage 
Aliquots of the libraries were screened with fibronectin fragments coated 
on microtiter wells. Panning was performed on each fragment individu- 
ally. In the first and second panning the coating concentration of protein 
was 5 ~g/well. To increase the stringency of the panning, the wells were 
coated  with  decreasing concentrations of protein  (1  and 0.1  p,g/weli). 
Phage were selected for further amplification from the well with the low- 
est protein concentration that showed phage binding over background. In 
the  fourth panning, the concentration  was  10 ng/well.  To  recover  the 
bound phage, the wells were eluted with 1 mM solution of GRGDSP or 
*CELRGDGWC* peptides, 2  mM EDTA,  or  were  directly  incubated 
with 50  Ixl of bacteria.  Phage were  sequenced from randomly selected 
clones as described (22). 
Phage Attachment Assay 
Binding of individual cloned phage to  insolubilized fibronectin and fi- 
bronectin fragments was studied in microtiter assays (22, 23). The coating 
concentration for the proteins was 10 p~g/ml. Coating with peptides was 
carried out at 10-t00 ixg/ml overnight with or without 1 mM divalent cat- 
ions. Phage binding was determined by growing K91kan bacteria in the 
presence of the selection marker tetracyclin. The absorbance at 600 nm 
was read after 16--24 h of incubation at room temperature (22).  Alterna- 
tively, the phage binding was also quantified by using sheep anti-M13 
polycIonal antibodies (1 vg/ml; Pharmacia). Readings at 450 nm were ana- 
lyzed after incubation with alkaline phosphatase conjugated anti-sheep 
IgG (1:10,000;  Sigma). 
Affinity Chromatography 
Peptides were  coupled to  Sepharose-CH  (Pharmacia)  according to  the 
manufacturer's instructions. Fibronectin and fibronectin fragments at 2 
mg/ml in TBS were applied onto the *CWDDGWLC*-Sepharose or to a 
control peptide column. After extensive washing with TBS, bound mate- 
rial was elnted with GRGDSP and GRGESP peptides (1 mM) or glycine 
(0.1 M) containing NaCl (0.1  M, pH =  3.0). Samples were concentrated 
when necessary and analyzed in SDS-PAGE pre-cast gradient mini gels. 
Proteins were visualized by Coomassie blue staining. 
Cell Attachment Assays 
An osteosarcoma cell line, MG-63, which attaches to fibronectin, vitronec- 
tin, and collagens through its complement of several integrins (37), was 
used in cell attachment assays to examine peptide inhibition of integrin 
function. Microtiter wells were coated with fibronectin, vitronectin or type 
IV collagen at concentrations that resulted in 60% of maximal attachment 
(~5 i~g/ml). Free binding sites on plastic were blocked with BSA. Approx- 
imately 1 ×  10  s cells per well were allowed to attach for 30 min in the pres- 
ence or absence of competing peptides and the bound cells were quanti- 
tated by staining with crystal violet (28). 
Immunization and Immunoblot Analysis 
RBF-Dnj mice (Jackson Laboratories, Bar Harbor, ME) were immunized 
with  the  *CWDDGWLC*  peptide  coupled  to  sheep  red  blood  cells 
(Sigma) according to the manufacturer's instructions. 
Purified cdIb133 (2 ixg/lane) and MG-63 cell extracts (20 ~1 from a vol/ 
vol detergent/cell pellet solution) were separated on 4-12% gradient SDS- 
PAGE  and transferred to  Immobilon-P membranes. After blocking of 
non-specific sites, filters were probed with anti-*CWDDGWLC* (1:200) 
and  anti-133 cytoplasmic  domain  polyclonal  serum  (1:1,000).  Normal 
mouse and rabbit sera were used as negative controls. Reactivity of anti- 
bodies was detected with anti-mouse or rabbit  IgG, and chemilumines- 
cence (ECL; Amersham). 
Results 
Isolation of Phage Capable of Binding 
to Fibronectin Fragments 
To identify peptide  motifs  that  interact  with  the  RGD- 
containing 10th type III domain of fibronectin (III10), re- 
combinant fibronectin fragments were used to select clones 
from a mixture of peptide libraries by successive rounds of 
affinity  panning  and  elution  with  RGD-containing  pep- 
tide. Decreasing protein coating concentration in the sec- 
ond and  third rounds,  and the use of excess of phage to 
introduce  binding  competition,  allowed  for  selection  of 
specific,  high-affinity  phage  50-  to  150-fold  enrichment 
was achieved on IIIi0-bearing fragments in the third round 
of panning (Fig. 1). The fragment containing the  10  lh and 
11 th type III repeats of fibronectin was the most efficient 
binder of specific phage. Enrichment was also seen on the 
recombinant  fibronectin  fragment  bearing  the  III10  do- 
main alone, but not on the fragment from the alternatively 
spliced  fibronectin  domain  containing  the  CS-1  binding 
site for a4f31 integrin (18) (results not shown). Binding of 
phage to fragment III8,9 was also low, indicating that the 
IIIt0 domain was important for the enrichment of RGD- 
eluted  phage.  GST and  BSA  were  used  as  controls  for 
non-specific  attachment  and  showed  negligible  phage 
binding. Enrichment of specific phage was also seen with 
the RGD-coating fragments when the phage were eluted 
with  EDTA  or  collected  by direct  infection  of bacteria 
added to the washed wells (see below). 
Phage Selected by RGD-containing 
Fibronectin Fragments Display the 
*CWDD6/L  WLC  * Peptide Motif 
Sequences  of the  insert  in  the  phage  eluted  with  RGD 
peptides, EDTA, or recovered by direct incubation of bac- 
teria showed  that  ~80-85%  of the  clones  displayed  the 
motif WDDGWL  (Table  I).  Some  of the  other  motifs 
found were similar to the WDDGWL sequence; the gly- 
cine residue was frequently replaced by leucine. Further- 
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ments. Fibronectin fragments were immobilized  onto microtiter 
wells at t p.g/weI1.  Phage libraries dispIaying CXsC, CX6C, CXTC, 
and CX9 peptides were plated and bound phage were eluted with 
a  cyclic RGD peptide.  Results  illustrate  the number of phage 
(transducing  units  ×  10  3) eluted from each well coated with in- 
dividual fragments in the third round of panning. 
more, the WDDGWL sequence was not encoded by a sin- 
gle clone, since there was variation at the nucleotide level 
among the phage. 
Binding of WDDGWL Phage to the III10 Domain Is 
Blocked with Synthetic Peptides 
The  specificity  of  the  WDDGWL-phage  binding  to  fi- 
bronectin and fibronectin fragments was tested in a micro- 
titer assay. The binding was dependent on the presence of 
the III10 domain (Fig. 2 a). Binding to III8,9, to control pro- 
teins (BSA and GST) and also to the fragment encompass- 
ing the alternatively spliced cell attachment domain of fi- 
bronectin  (not shown) was minimal. An unrelated  phage 
Table L Selection of Peptides Binding to Fibronectin 
Type lll  :o~RGD;-containing Fragments  from Phage 
Display Peptide Libraries 
RGD elution  EDTA elution  Direct infection of wells 
WDDGWL (131)  WDDGWL (21) 
WDDLWWL (10)  LVWLLVQFY (2) 
WDDGLM (7)  TFGGGIGRV (l) 
WDDGWM (4)  TLRFQRS (1) 
WDDGWL (45) 
SWDDGWL (6) 
PDDLWWL (3) 
DGWLGF (2) 
QRIVLGFT (1) 
DYWLGF (1) 
FVLWLV (1) 
GNRLR (1) 
Peptide sequences displayed by phage isolated by different elution strategies. The 
number of phage displaying the same amino acid motif is indicated in parenthesis. 
displaying the  peptide RDPRAQDL showed no binding 
to fibronectin or any of its fragments. 
Two cyclic peptides, *CWDDGWLC* and A*CRGDG- 
WMC*G, were synthesized and tested for their ability to 
inhibit  phage binding  to  the  III10al fragment.  Both pep- 
tides,  but  not  an  irrelevant  cyclic one,  inhibited  WDD- 
GWL-phage binding in a dose-dependent manner (Fig. 2 
b).  EDTA  did  not  inhibit  the  binding  of WDDGWL- 
phage  (not  shown),  although  we  had  detected  WDD- 
GWL-phage in the EDTA eluates after affinity panning. 
The recovery of the WDDGWL-phage with EDTA (Ta- 
ble  I) may have  represented  non-specific release  of the 
bound phage rather than specific elution, because less phage 
was eluted than with the RGD peptide. 
Phage Attachment to Immobilized Peptides 
The binding of WDDGWL and RGD-displaying phage to 
RGD and WDDGWL-containing peptides was analysed in 
phage attachment assays using *CWDDGWLC*, A*CRG- 
DGWMC*G,  and  an  irrelevant  cyclic  peptide  as  sub- 
strates. We were able to show that WDDGWL-phage can 
bind to the RGD-containing peptide. Conversely, RGD- 
phage can bind  to  the  *CWDDGWLC*-containing  pep- 
tide  (Fig.  3  a).  The  RGD  phage also  showed  slight,  but 
consistent,  binding  to  the  peptide  displaying  the  same 
RGD motif, RGDGW. Addition of either the *CWDDG- 
WLC* or A*CRGDGWMC*G peptide in solution blocked 
the WDDGWL-phage binding (Fig. 3 b), whereas an un- 
related peptide had no effect (not shown). The binding of 
RGD-phage was also inhibited by both peptides, and was 
unaffected by the control peptide (Fig. 3 c) or by EDTA 
(not shown). 
Fibronectin Binds to *CWDDGWLC* Sepharose 
Affinity chromatography showed  that  fibronectin bound 
to  *CWDDGWLC*-Sepharose, and was eluted  with the 
GRGDSP  peptide  but  not  with  the  GRGESP  peptide 
(Fig. 4 a). Fibronectin was not retained in a control unre- 
lated peptide column (not shown). Fibronectin fragments 
lacking the III10 domain and unrelated proteins (BSA and 
type  IV collagen)  were  not  retained  in  the  *CWDDG- 
WLC*-Sepharose  column.  The  difference  between  the 
binding  of the  IIIqA  0 (RGD+)  and  III8,  9 (RGD-)  frag- 
ments to the *CWDDGWLC* column is shown in Fig. 4 b. 
*CWDDGWLC* Inhibits RGD-dependent 
Cell Adhesion 
The *CWDDGWLC* peptide inhibited cell adhesion when 
either fibronectin or vitronectin were used  as substrates, 
but not on collagen (Fig. 5).  An unrelated  cyclic peptide 
had no effect on any of the substrates.  *CWDDGWLC* 
was slightly less effective than the standard RGD peptide, 
GRGDSP (not shown). 
*CWDD~/L  WLC  * Resembles a Peptide 
from f13 Integrin Subunit 
A  DDLW sequence from the ligand binding region of the 
[~ subunits  shows similarity to our RGD binding peptide 
motif.  A  synthetic  peptide  containing  the  DDLW  se- 
quence  of  the  [33  subunit  (amino  acids  109-133;  DYP- 
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Figure 2.  Phage  attachment 
assay. (a) Purified WDDGWL 
phage  was  incubated  in  mi- 
crotiter  wells  coated  with 
various fibronectin  fragments 
immobilized  onto  microtiter 
wells and bound phage were 
quantified  by  the  absor- 
bance  indicative  of  relative 
bacterial  growth.  These  re- 
sults  are  representative  of 
three  separate  experiments. 
Points represent the mean of 
triplicate  determinations with 
standard  error  less  than 
10%  of the mean.  i, Fn; [], 
FnlII8_ll;  [~,  FnlII~o.11; 7~, 
Fnliig.lo;  [~,  Fnliis.9;  I1, 
BSA; D, no phage.  (b) Inhi- 
bition  of  the  binding  of 
*  CWDDGWLC *--expressing 
phage to the IIIs.ll fibronec- 
tin fragment by synthetic peptides. WDDGWL-phage binding to the IIIs_la fragment was analyzed as described in a, in the presence of 
the  competing peptides  indicated.  The  bound  phage  was  quantified  as  described  above.  ~,  GA*CVRLNSLAC*GA;  •  , 
A*CRGDGWMC*G; ---O--, *CWDDGWLC*. 
VDIYYLMDLSYSMK DDLWSIQN)  binds  to an  RGD 
peptide (9). As shown in Fig. 6, RGD-phage bound to the 
113(109-133)  peptide. The binding required the presence of 
divalent cations, either while the peptide was coated onto 
plastic or during the phage binding (Fig. 6 a). The binding 
of the RGD-phage binding was blocked by the addition of 
soluble *CWDDGWLC* or GRGDSP peptides (Fig. 6 b). 
The two peptides were equally effective; in titration exper- 
iments  50%  inhibition  was achieved  at  about  1  I~M con- 
centration  of the peptides  (not shown). However, EDTA 
did not block phage binding when peptides  were allowed 
to coat in the presence of cations. 
To  establish  whether  the  DDLW  sequence  in  the  113 
(109-133)  peptide  was  important  for  the  RGD-phage 
binding, we synthesized a variant [33 peptide in which both 
Asp  126  and  Asp  127  were  replaced  by Ala  (DYPVDI- 
YYLMDLSYSMKAALWSIQN). RGD-phage binding to 
this AA variant was much weaker than to the DD peptide 
(Fig. 6), indicating an important role for the two aspartate 
residues in the interaction. The residual binding to the AA 
peptide  had the same cation requirements  as the binding 
to the wild type peptide. 
Figure 3.  Binding of phage to immobilized peptides in the pres- 
ence or absence of soluble peptides. RGD- and WDDGWL-con- 
taining peptides were coated on microtiter wells at 20 p~g/ml and 
used to bind phage expressing the same motifs.  Soluble peptides 
were  added  at  1 mM concentration.  The  data  represent  mean 
from triplicate  wells  with  standard  error less  than  10%  of the 
mean. (a) l, WDDGWL phage; [~, ELRGDGW phage; [], RD- 
PRAQDL phage, (b and c) i, *CWDDGWLC*; [], *CRGDG- 
WMC*; [], no inhibition. 
Antibodies against *CWDDGWLC* Peptide Recognize 
~3 and ~31 in Immunoblots 
Further  evidence  for  the  structural  similarity  between 
*CWDDGWLC* and  [3 subunits  was obtained with  anti- 
bodies raised against *CWDDGWLC* peptide. When pu- 
rified c~IIb133  was probed in immunoblots with anti-*CWD- 
DGWLC*,  a  band  was  detected  that  had  the  expected 
molecular size of 113 and aligned with the band detected by 
anti-113  cytoplasmic domain antiserum  (Fig. 7 a). Reactiv- 
ity of the anti-*CWDDGWLC* serum could be abrogated 
by preincubation  of the  serum  with  either  the  *WDDG- 
WLC* or the  [33 (109-133) peptide  (Fig. 7 a, lanes  C  and 
D, respectively). The anti-*CWDDGWLC* serum also re- 
acted with bands that co-migrated with 131 and 113 subunits 
in  MG-63  total  cell  extracts  (Fig.  7  b,  lane  E).  Anti-111 
monoclonal antibody TS2/16 against 131 was used as a pos- 
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Figure  4.  Binding  of  fibronectin  and 
fibronectin  fragments  to  *CWDDG- 
WLC*-Sepharose.  (a) Two mg of purified 
fibronectin  were  applied  into  a  *CWD- 
DGWLC*-Sepharose column (lane S rep- 
resents a sample of the starting  material). 
Bound  material  was  eluted  by  applying 
GRGDSP or GRGESP peptides at 1 raM. 
The  eluted  fractions  were  analyzed  in 
SDS-PAGE and protein was visualized by 
Coomassie blue staining.  (b) Fibronectin 
fragments IIIg,10  and III8.9  and BSA as a 
control were fractionated on a *CWDDG- 
WLC*-Sepharose  column.  Bound  mate- 
rial was eluted with glycine/NaC1 at pH 3.0 
and the fractions  were analyzed  for pro- 
tein by measuring OD 280. 
itive  control  (Fig.  7  b,  lane  E).  The  reactivity  of  anti- 
WDDGWL serum was abrogated by pre-incubation of the 
antiserum with either *WDDGWLC* or [33 (109-133) (Fig. 
7 b, lanes C and D, respectively); these peptides had no ef- 
fect on the reactivity of the positive control antibodies in 
a orb. 
Discussion 
We have used phage peptide libraries to identify a  cyclic 
peptide motif, represented by the  sequence  WDDGWL, 
that binds to the RGD-containing domain of fibronectin. 
This  motif seems to  be  a  structural  mimic of an  RGD- 
binding site in integrin ~3 subunits. 
The WDDGWL sequence and its variations (flanked by 
cysteine residues engineered into the libraries) was by far 
the  most frequently isolated sequence  on the  RGD-con- 
taining  fibronectin  fragments.  The  sequences  that  were 
not  related  to  the  WDDGWL  motif were  hydrophobic 
and/or seen only once. The binding of these phage is likely 
to have been non-specific; they were lost in the subsequent 
high affinity screening steps and were not seen at all when 
specific elution with an RGD peptide was used. 
The binding of the WDDGWL phage to the RGD-con- 
taining  fragments was specific because  only background 
binding  was  seen  when  fragments  lacking  the  RGD- 
containing  III10 domain,  or  control  proteins,  were  used. 
Moreover, panning performed using the function-blocking 
anti-cxlIb[33  monoclonal  antibodies,  PAC-1,  OPG2,  and 
LJ-CP3, which each contain an RYD sequence as an RGD 
mimic (1, 44, 45), also yields the WDDGWL motif as the 
predominant motif (Pasqualini,  R., and E. Ruoslahti, un- 
published data). Finally, the specificity of the WDDGWL- 
phage binding to the fibronectin fragments was also sup- 
ported  by  specific  inhibition  of the  interaction  both  by 
peptides representing  the  motif itself and by RGD-pep- 
tides. This latter result and the ability of a  cyclic peptide 
containing  the  WDDGWL motif to bind phage that  dis- 
play the RGD sequence also show that the binding site for 
the WDDGWL encompasses the RGD sequence itself. 
The DDL sequence, which according to our data is an 
RGD-contact region,  is conserved in  several [3  subunits. 
Variability in  the  amino  acid  residues  adjacent  to  DDL 
(see Table If) may explain the differences in the ability of 
integrins containing different [3 subunits to bind to RGD- 
containing ligands. Because several contact areas may be 
necessary for  ligand  binding,  regions  in  the  c~ chain  are 
also likely to  affect integrin  specificity. In the  [3  subunit 
binding  site,  the  tryptophan residue,  only present  in  [33, 
may be important because it was nearly invariant in  the 
phage that bound avidly to the RGD ligands. 
Phage-peptide  binding  studies  revealed  a  preliminary 
result that deserves comment. As shown in Fig. 3 a, there 
was some binding by phage displaying the sequence RG- 
DGW to an immobilized peptide containing this same mo- 
tif.  As  the  RGDGW  sequence  has  some similarity  with 
WDDGWL, it may be that the RGDGW motif mimics the 
integrin while also being self-complementary. It has been 
proposed that receptor-ligand pairs arise in evolution from 
sequences  that  occur frequently in proteins, because the 
probability  for  a  newly  emergent  receptor  (or  ligand) 
would find a  useful ligand  (or receptor) is greatest when 
the reciprocal binding sequence is common (32);  Our re- 
sults suggest an alternative scenario for the emergence of 
the  integrin-RGD  recognition  system,  i.e.,  self  comple- 
mentarity. 
The  fact  that  the  *CWDDGWLC*  peptide  binds  to 
both fibronectin  and  vitronectin  (and  apparently also  to 
antibodies  that  mimic RGD-containing ligands)  suggests 
that  such  peptide  might  be  useful  in  the  isolation  of 
unknown  integrin  ligands.  Conversely,  antibodies  made 
against the peptide may be used to identify new integrin [3 
subunits. 
The WDDGWL motif places the  RGD binding site to 
the same region of the ~ subunit that was identified in ear- 
lier studies (Table II) (2, 3, 6, 8). This motif also pinpoints 
the binding site  further.  The smallest RGD-binding pep- 
tide from integrin sequences so far has been the 23-amino 
acid peptide of D'Souza et al. (9) which contains both a di- 
valent cation  binding  site  and  the  WDDGWL similarity 
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Figure  5.  Inhibition of  cell  attachment to  fibronectin and  vi- 
tronectin by *CWDDGWLC* peptide. Fibronectin (Fn), type IV 
collagen (Col),  or  vitronectin (Vn)  were  coated  onto  96-well 
plates.  The MG-63 osteosarcoma cells were allowed to attach in 
the presence of increasing concentrations of the indicated pep- 
tides.  Attached cells were fixed  and stained with crystal  violet. 
The data represent means of OD600 values from triplicate wells. 
~,  *CVRLNSLAC*; --[~-, *CWDDGWLC*. 
Figure 6.  Binding of RGD-phage to peptides from the [33 inte- 
grin  subunit.  (a)  Synthetic peptide  (DYPVDIYYLMDLSYS- 
MKDDLWSIQN), "DD" and (DYPVDIYYLMDLSYSMKAA- 
LWSIQN), "AA" were coated at 100 Ixg/ml onto microtiter wells 
in  the  presence  or  absence  of  1  mM  divalent cations.  EL- 
RGDGW-phage was  incubated in the presence or absence of 
EDTA (10 raM) or calcium or magnesium (1 mM). Antibodies 
against M13 phage were used to quantify the amount of bound 
phage.  Phage  displaying an  unrelated peptide  sequence, RD- 
PRAQDL was tested as a control phage. (a) [], Calcium; II, mag- 
nesium; [], no cations; [], EDTA; D, ctr phage. (b) The effect of 
soluble GRGDSP or *CWDDGWLC* peptides on the binding  of 
phage to the same integrin peptides as in a was analyzed. The 
data in a  and b represent the means from triplicate wells with 
standard error less than 10%  of the mean. II, Magnesium; [], 
*CWDDGWLC*; N, GRGDSP; D, ctr phage. 
region. Mutagenesis of residues in the cation binding motif 
eliminates divalent cation binding or reduces ligand bind- 
ing by the whole integrin. However, one such mutation of 
Asp  119  to  tyrosine (see  Table II), while rendering the 
whole integrin inactive, fails to affect RGD binding by the 
binding region peptide (9). Our results with the [33 subunit 
peptide are similar to those of D'Souza et. al. (9), but we 
found that the presence of divalent cations is required for 
RGD  binding either when the  peptide  was  coated  onto 
plastic, or during the binding assay. We were using a cyclic 
RGD peptide displayed on phage, whereas D'Souza et al. 
The Journal  of Cell Biology, Volume 130, 1995  1194 Figure  7.  Immunoblot analysis  of  anti-*CWDDGWLC*  antise- 
rum. (a) Purified Mlb133 was separated on SDS-PAGE and trans- 
ferred to Immobilon-P membranes. The filters were probed with 
normal anti-*CWDDGWLC* serum (1:500) and anti-J33  cytoplas- 
mic domain sera (1:2000) (lanes E  and F, respectively). (b) MG-63 
ostcosarcoma cell  extracts were processed in the same way and 
probed with  anti-*CWDDGWLC*  and with TS2/16  (10  ~g/ml), 
an  anti-[31  monoclonal  antibody  (lanes  E  and  F,  respectively). 
Normal rabbit and mouse sera were used as controls both in a  and 
b  (lanes A  and B). In lanes C  and D, filters were incubated with 
anti-*CWDDGWLC*  serum in  the  presence of  100  ~M  of the 
*CWDDGWLC* or the [33 (119-133) peptides in solution. 
used a synthetic RGD peptide, and the divalent cation re- 
quirements for the binding of different ligands to the same 
binding structure  on the  integrin may vary (25).  As  the 
WDDGW  motif  lacks  the  divalent  cation  binding  se- 
quence, which is at the NH2 terminus of the peptide (9), 
we suggest the following model for the RGD binding: The 
actual RGD binding site is predominantly located in the 
WDDGW  similarity  region,  and  in  the  intact  integrin 
the activity of this site depends on the binding of a cation 
to  the  adjoining  divalent  cation  binding  site;  the  cyclic 
WDDGWL peptide may assume  the  RGD-binding con- 
formation without divalent cation binding because the di- 
sulfide  bond  stabilizes  the  RGD-binding  conformation. 
The binding of an RGD ligand may in turn affect the diva- 
lent cation binding site, as it causes extrusion of the cation 
from the integrin (9). 
One earlier result would not appear to agree with our 
hypothesis that the DDLW sequence in the integrin could 
be important in ligand binding; Bajt et al.  (3) found that 
mutating the aspartic acid residues in this sequence to ala- 
nines did not appreciably affect the binding of the alIb[33 
integrin to fibrinogen. A possible explanation of this result 
is that ~IIb[33 is known to recognize the "V chain KQGDV 
sequence in fibrinogen, and unlike RGD peptides which 
bind to the 13 subunit, this sequence binds mostly to the 
Table II. Comparison of the RGD-binding Sequence from 
Peptide Library with Integrin Sequences 
cw~c 
[33: DLYYLMDLSY SM KIDD LWjS  I QNLGTKLAT 
[31: DLYYLMDLSY S M KJD D LIE NVKSLGTDLMN 
[35:DLYYLMDLSLSMK[DD LID N  I RSLGTKLAEE 
[36:DLYYLMDLSAAMD~N  T  I KELGSGLSKE 
(113-153) 
The amino acid sequences of integrin 13 subunits are shown using the single-letter 
code. Residues D119, D126, and D127 within the 133 subunit are underlined. 
subunit as measured by affinity labeling (36, 39). The bind- 
ing  of  the  mutant  alIb[33  integrin  to  the  RGD-mimic 
OPG2 antibody was lost and, as the WDDGWL similarity 
region appears to be the RGD binding site, it may be that 
changes in this region within intact integrins would affect 
only the binding of RGD ligands. 
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